Will TNX-102 SL Receive FDA Approval for the Treatment of Fibromyalgia?
1
100Ṁ15
2026
57%
chance

This market predicts whether the FDA will approve TNX-102 SL for treating fibromyalgia. The FDA has accepted the NDA and given Fast Track designation. Resolution will be based on official FDA announcements and Tonix press releases.

References:

FDA
Medicine
Get
Ṁ1,000
to start trading!

People are also trading

Will there be an FDA Approved treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by 2030.
35% chance
When will the "100% effective against solid tumors" cancer pill AOH1996 be approved by the FDA?
Will the FDA approve MAIA Biotechnology's THIO-101 for the treatment of advanced Non-Small Cell Lung Cancer by Jan 2030?
84% chance
Zuranolone gets FDA approval for some other condition
48% chance
Will FDA approve any mRNA vaccine against Lyme disease before 2028?
27% chance
Zuranolone gets FDA approval for major depression
43% chance
Will AOH1996 be FDA approved before 2040?
40% chance
When will the "100% effective against solid tumors" cancer pill AOH1996 be approved by the FDA?
By 2029, will there be an FDA approval of GLP-1 for a substance use disorder?
86% chance
© Manifold Markets, Inc.•Terms•Privacy